Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
22 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/22/3119817/0/en/Rhythm-Pharmaceuticals-to-Report-Second-Quarter-2025-Financial-Results-on-Tuesday-August-5-2025.html
12 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/12/3114398/0/en/Rhythm-Pharmaceuticals-Presents-Data-on-MC4R-Agonists-Setmelanotide-and-Bivamelagon-at-ENDO-2025.html
10 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/10/3113078/0/en/Rhythm-Pharmaceuticals-Inc-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112888/0/en/Rhythm-Pharmaceuticals-Inc-Announces-Proposed-Public-Offering-of-Common-Stock.html
09 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/rhythms-phase-2-obesity-pill-trial-hits-primary-endpoint-sending-stock
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112491/0/en/Rhythm-Pharmaceuticals-Announces-Oral-MC4R-Agonist-Bivamelagon-Achieved-Statistically-Significant-Clinically-Meaningful-BMI-Reductions-in-Placebo-controlled-Phase-2-Trial-in-Acquir.html
ABOUT THIS PAGE